ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

LXEO Lexeo Therapeutics Inc

5.43
0.18 (3.43%)
01 Feb 2025 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)
Total Revenue 0000
Operating Income -14.97M-23.29M-23.55M-31.54M
Pre Tax Income -14.19M-21.68M-21.24M-29.49M
Net Income -14.19M-21.68M-21.24M-29.49M
Preferred Dividends 0000
Basic Earnings Per Share (EPS) 0000
EBIT -15.24M-23.3M-23.55M-31.55M
EBITDA -14.9M-23.22M-23.47M-31.46M
Year End 31 December 2023 202120222023
USD (US$)USD (US$)USD (US$)
Total Revenue 1.66M654k0
Operating Income -50.64M-60.51M-68.51M
Pre Tax Income -50.62M-59.28M-66.39M
Net Income -50.62M-59.28M-66.39M
Preferred Dividends 000
Basic Earnings Per Share (EPS) -3.023-3.481-40.658
EBIT -50.64M-60.51M-69.06M
EBITDA -50.62M-60.39M-68.24M

Your Recent History

Delayed Upgrade Clock